China Innovation, Large Market Continue To Lure Foreign Investment

Robust Activity Despite De-Risking

Investment and potential growth
Global biopharmas expand their investments in manufacturing upgrade and biotech innovation in China (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Scrip

More from Business